OrthoPulse Gen 2 Initial Device Evaluation and Assessment of Clinical Effectiveness (CA)

NCT ID: NCT04386278

Last Updated: 2020-11-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

56 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-01-08

Study Completion Date

2020-06-24

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a prospective, interventional, non-randomized, control, split-mouth, open-label, single centre, private practice study aimed to evaluate the effect of tooth movement during orthodontic treatment using a removeable thermoplastic orthodontic appliance. Intrusion and extrusion will be conducted using bilaterally equivalent elastomeric forces of 50 grams.

A comparison of the rate of bilateral orthodontic tooth movement will be conducted using six (6) varied photobiomodulation interventions on the maxillary (upper) and mandibular (lower) arches. The OrthoPulse Gen 2 and OrthoPulse (commercially approved) devices are being used in this clinical investigation. Each subject enrolled will go through intrusion and extrusion.

All subjects will be allocated to an OrthoPulse split-mouth intervention by the investigator.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Orthodontic Tooth Movement

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Each group in this study includes a different device iteration that is being investigated in parallel.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention 1

Side one: No treatment Side two: OrthoPulse Gen 2 (2RP) for one minute

Group Type EXPERIMENTAL

Intervention 1

Intervention Type DEVICE

Side one: No treatment Side two: OrthoPulse Gen 2 (2RP) for one minute

Intervention 2

Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (2RP) for one minute

Group Type EXPERIMENTAL

Intervention 2

Intervention Type DEVICE

Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (2RP) for one minute

Intervention 3

Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (2RP) for 5 minutes

Group Type EXPERIMENTAL

Intervention 3

Intervention Type DEVICE

Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (2RP) for 5 minutes

Intervention 4

Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (2RCW) for five minutes

Group Type EXPERIMENTAL

Intervention 4

Intervention Type DEVICE

Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (2RCW) for five minutes

Intervention 5

Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (3RB 2RL) for one minute

Group Type EXPERIMENTAL

Intervention 5

Intervention Type DEVICE

Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (3RB 2RL) for one minute

Intervention 6

Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (3RB 2RL) for five minutes

Group Type EXPERIMENTAL

Intervention 6

Intervention Type DEVICE

Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (3RB 2RL) for five minutes

Intervention 7

Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (3RB 2RL) for one minute

Group Type EXPERIMENTAL

Intervention 7

Intervention Type DEVICE

Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (3RB 2RL) for one minute

Intervention 8

Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (3RB 2RL) for five minutes

Group Type EXPERIMENTAL

Intervention 8

Intervention Type DEVICE

Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (3RBP) for five minutes

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intervention 1

Side one: No treatment Side two: OrthoPulse Gen 2 (2RP) for one minute

Intervention Type DEVICE

Intervention 2

Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (2RP) for one minute

Intervention Type DEVICE

Intervention 3

Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (2RP) for 5 minutes

Intervention Type DEVICE

Intervention 4

Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (2RCW) for five minutes

Intervention Type DEVICE

Intervention 5

Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (3RB 2RL) for one minute

Intervention Type DEVICE

Intervention 6

Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (3RB 2RL) for five minutes

Intervention Type DEVICE

Intervention 7

Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (3RB 2RL) for one minute

Intervention Type DEVICE

Intervention 8

Side one: OrthoPulse (approved device) Side two: OrthoPulse Gen 2 (3RBP) for five minutes

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient must be 19 years of age or older
* Likely to be compliant to OrthoPulse use, aligner wear, and Dental Monitoring scanning
* Have a compatible iOS or Android device and are willing to download the OrthoPulse and Dental Monitoring apps for frequent automatic syncing of data

Exclusion Criteria

* Patient is currently enrolled in another clinical study
* Crowding or rotations of bilateral bicuspids that would prevent or interfere with intrusion
* Periodontally involved teeth, acute oral infection or periodontal disease
* Patient has active/untreated caries
* Use of bisphosphonates at any time
* Use of drugs that may cause photosensitivity
* History of photosensitivity
* Epilepsy
* Pregnant or planning pregnancy during the study.
* Patient plans to relocate over the treatment period
Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Biolux Research Holdings, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dr. Peter Brawn

Vancouver, B.C, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RI.2

Identifier Type: -

Identifier Source: org_study_id